Access to orphan drugs–comparison across Balkan countries

AV Pejcic, G Iskrov, MM Jakovljevic, R Stefanov - Health Policy, 2018 - Elsevier
The aim of this study was to compare orphan drug access in a sample of Balkan countries:
five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) and two EU …
被引用次数：26 相关文章

Access to orphan drugs-comparison across Balkan countries.

AV Pejcic, G Iskrov, MM Jakovljevic… - Health Policy …, 2018 - europepmc.org
The aim of this study was to compare orphan drug access in a sample of Balkan countries:
five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) and two EU …

Access to orphan drugs–comparison across Balkan countries

AV Pejcic, G Iskrov, MM Jakovljevic, R Stefanov - Health Policy, 2018 - ideas.repec.org
The aim of this study was to compare orphan drug access in a sample of Balkan countries:
five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) and two EU …

Access to orphan drugs-comparison across Balkan countries.

AV Pejcic, G Iskrov, MM Jakovljevic, R Stefanov - 2018 - cabidigitallibrary.org
The aim of this study was to compare orphan drug access in a sample of Balkan countries:
five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) and two EU …

Access to orphan drugs–comparison across Balkan countries

A Pejcic, G Iskrov, M Jakovljevic, R Stefanov - 2018 - scidar.kg.ac.rs
© 2018 Elsevier BV The aim of this study was to compare orphan drug access in a sample of
Balkan countries: five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) …

Access to orphan drugs–comparison across Balkan countries

AV Pejcic, G Iskrov, MM Jakovljevic… - Health Policy, 2018 - econpapers.repec.org
The aim of this study was to compare orphan drug access in a sample of Balkan countries:
five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) and two EU …

Access to orphan drugs-comparison across Balkan countries

AV Pejcic, G Iskrov, MM Jakovljevic… - Health Policy, 2018 - portal.research.lu.se
The aim of this study was to compare orphan drug access in a sample of Balkan countries:
five EU Member States (Bulgaria, Croatia, Greece, Romania, Slovenia) and two EU …